Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases
Rinda Devi Bachu(University of Toledo), Sai H. S. Boddu(University of Toledo), Zahraa Hasan Falhi Al-Saedi(University of Toledo), Pallabitha Chowdhury(University of Toledo), Pradeep K. Karla(Howard University)
Cited by 408
Related Papers
Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9
|Molecular Pharmacology|2010|68
Polyamide/Poly(Amino Acid) Polymers for Drug Delivery
|Journal of Functional Biomaterials|2021|65
Molecular evidence and functional expression of a novel drug efflux pump (ABCC2) in human corneal epithelium and rabbit cornea and its role in ocular drug efflux
|International Journal of Pharmaceutics|2006|59
Molecular Expression and Functional Evidence of a Drug Efflux Pump (BCRP) in Human Corneal Epithelial Cells
|Current Eye Research|2009|57
Recent Patents on Ophthalmic Nanoformulations and Therapeutic Implications
|Recent Patents on Drug Delivery & Formulation|2014|47